Location of Repository

An RND-Type Efflux System in Borrelia burgdorferi Is Involved in Virulence and Resistance to Antimicrobial Compounds

By Ignas Bunikis, Katrin Denker, Yngve Östberg, Christian Andersen, Roland Benz and Sven Bergström

Abstract

Borrelia burgdorferi is remarkable for its ability to thrive in widely different environments due to its ability to infect various organisms. In comparison to enteric Gram-negative bacteria, these spirochetes have only a few transmembrane proteins some of which are thought to play a role in solute and nutrient uptake and excretion of toxic substances. Here, we have identified an outer membrane protein, BesC, which is part of a putative export system comprising the components BesA, BesB and BesC. We show that BesC, a TolC homolog, forms channels in planar lipid bilayers and is involved in antibiotic resistance. A besC knockout was unable to establish infection in mice, signifying the importance of this outer membrane channel in the mammalian host. The biophysical properties of BesC could be explained by a model based on the channel-tunnel structure. We have also generated a structural model of the efflux apparatus showing the putative spatial orientation of BesC with respect to the AcrAB homologs BesAB. We believe that our findings will be helpful in unraveling the pathogenic mechanisms of borreliae as well as in developing novel therapeutic agents aiming to block the function of this secretion apparatus

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2279261
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2005). A
    2. (1986). A Borrelia-specific monoclonal antibody binds to a flagellar epitope.
    3. (1994). A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of gramnegative bacteria.
    4. (2003). A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection.
    5. (2000). A multidrug efflux transporter in Listeria monocytogenes.
    6. (2007). A periplasmic coiled-coil interface underlying TolC recruitment and the assembly of bacterial drug efflux pumps.
    7. (2003). aadA confers streptomycin resistance in Borrelia burgdorferi.
    8. (2001). AcrAB and related multidrug efflux pumps of Escherichia coli.
    9. (1999). Alignment and structure prediction of divergent protein families: periplasmic and outer membrane proteins of bacterial efflux pumps.
    10. (2002). An aspartate ring at the TolC tunnel entrance determines ion selectivity and presents a target for blocking by large cations.
    11. (1994). Analysis of Borrelia burgdorferi membrane architecture by freeze-fracture electron microscopy.
    12. (1991). Analysis of outer membrane ultrastructure of pathogenic Treponema and Borrelia species by freeze-fracture electron microscopy.
    13. (2004). BBE02 disruption mutants of Borrelia burgdorferi B31 have a highly transformable, infectious phenotype.
    14. (2006). Bergstro ¨m S
    15. (1999). Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli.
    16. (2004). CD-Search: protein domain annotations on the fly. Nucleic Acids Res 32: W327–331.
    17. (1990). Cefotaxime versus penicillin in the late stage of Lyme disease–prospective, randomized therapeutic study.
    18. (2003). Channel-tunnels: outer membrane components of type I secretion systems and multidrug efflux pumps of Gram-negative bacteria.
    19. (1995). Characterization of outer membranes isolated from Borrelia burgdorferi, the Lyme disease spirochete.
    20. (2000). Chunnel vision. Export and efflux through bacterial channel-tunnels.
    21. (2002). Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background.
    22. (2000). Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates.
    23. (2000). Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export.
    24. (2004). Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end.
    25. (2006). Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence.
    26. (2000). Discovery of a novel channel-forming protein in the cell wall of the non-pathogenic Nocardia corynebacteroides.
    27. (2000). DNA exchange and insertional inactivation in spirochetes.
    28. (2004). Drug efflux and protein export through channel-tunnels;
    29. (2000). Efficient targeted mutagenesis in Borrelia burgdorferi.
    30. (2001). Efflux pumps: their role in antibacterial drug discovery.
    31. (2004). Efflux-mediated drug resistance in bacteria.
    32. (2007). Elimination of channel-forming activity by insertional inactivation of the p66 gene in Borrelia burgdorferi.
    33. (1989). Enzyme-linked immunosorbent assays for Lyme disease: reactivity of subunits of Borrelia burgdorferi.
    34. (2004). Essential role for OspA/B in the life cycle of the Lyme disease spirochete.
    35. (2006). Evidence for a dimeric assembly of two titin/telethonin complexes induced by the telethonin C-terminus.
    36. (1996). Evidence that TolC is required for functioning of the Mar/ AcrAB efflux pump of Escherichia coli.
    37. (1978). Formation of large, ion-permeable membrane channels by the matrix protein (porin) of Escherichia coli.
    38. (1994). Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB.
    39. (2002). Identification of modified proteins by mass spectrometry.
    40. (2006). Importance of the adaptor (membrane fusion) protein hairpin domain for the functionality of multidrug efflux pumps.
    41. (1987). Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels.
    42. (2001). In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi.
    43. (1987). In vitro and in vivo susceptibility of Borrelia burgdorferi.
    44. (1985). Ion selectivity of Gram-negative bacterial porins.
    45. (1979). Ionic selectivity of pores formed by the matrix protein (porin) of Escherichia coli.
    46. (1984). Isolation and cultivation of Lyme disease spirochetes.
    47. (1982). Lyme disease-a tick-borne spirochetosis?
    48. (1996). Multidrug efflux pumps of gram-negative bacteria.
    49. (2002). Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa.
    50. (1998). Multiple antibiotic resistance and efflux.
    51. (1993). Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.
    52. (2003). New antibiotic resistance cassettes suitable for genetic studies in Borrelia burgdorferi.
    53. (2000). New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances.
    54. (1991). New pUC-derived cloning vectors with different selectable markers and DNA replication origins.
    55. (2001). P13, an integral membrane protein of Borrelia burgdorferi, is C-terminally processed and contains surface-exposed domains.
    56. (1994). Prevention of drug access to bacterial targets: permeability barriers and active efflux.
    57. (1999). Probability-based protein identification by searching sequence databases using mass spectrometry data.
    58. (2001). Protein export and drug efflux through bacterial channel-tunnels.
    59. (2002). Proteintranslocating outer membrane porins of Gram-negative bacteria.
    60. (2002). Regulation of bacterial drug export systems. Microbiol Mol Biol Rev 66: 671–701, table of contents.
    61. (1992). Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans.
    62. (1996). Salmonella typhimurium acrB-like gene: identification and role in resistance to biliary salts and detergents and in murine infection.
    63. (1983). Spirochetes isolated from the blood of two patients with Lyme disease.
    64. (2006). Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism.
    65. (2004). Structure of the periplasmic component of a bacterial drug efflux pump.
    66. (1989). Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.
    67. (2006). The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis.
    68. (2006). The channel-tunnel HI1462 of Haemophilus influenzae reveals differences to Escherichia coli TolC.
    69. (2005). The crystal structure of the outer membrane protein VceC from the bacterial pathogen Vibrio cholerae at 1.8 A resolution.
    70. (2004). The emergence of Lyme disease.
    71. (1999). The farAB-encoded efflux pump mediates resistance of gonococci to long-chained antibacterial fatty acids.
    72. (1996). The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals.
    73. (2000). The natural evolutionary relationships among prokaryotes.
    74. (1997). The Oms66 (p66) protein is a Borrelia burgdorferi porin.
    75. (2003). The proteome of Saccharomyces cerevisiae mitochondria.
    76. (1983). The spirochetal etiology of Lyme disease.
    77. (2004). Three’s company: component structures bring a closer view of tripartite drug efflux pumps.
    78. (1993). TolC of Escherichia coli functions as an outer membrane channel.
    79. (2003). TolC–the bacterial exit duct for proteins and drugs.
    80. (2002). Transition to the open state of the TolC periplasmic tunnel entrance.
    81. (1994). Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport.
    82. (2006). Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.